This relatively high CD4+ T cell infiltration might also be responsible for the moderate effects regarding the immune checkpoint inhibitors observed for JA-2042, and displayed a significant tumor reduction by a combination antibody treatment [59]. The gene discussed is CD4; the disease is neoplasm.